Tag: prescription orthopedic drugs market forecast

Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Are The Future Growth Projections For The Prescription Orthopedic Drugs Market Size?

In recent times, there has been a robust growth in the prescription orthopedic drugs market. It is anticipated to escalate from $48.41 billion in 2024 to $51.06 billion in 2025, registering a compound annual growth rate (CAGR) of 5.5%. The formidable growth during the historic period is primarily due to the heightened prevalence of musculoskeletal disorders, surge in the elderly population, an augmented awareness of osteoporosis treatments, amplified healthcare accessibility in the underdeveloped regions, as well as the escalation of sports-oriented injuries globally.

The market for prescription orthopedic medications is predicted to experience substantial expansion over the upcoming years, growing to a size of “$63.86 billion by 2029 with an average annual growth rate (CAGR) of 5.8%. The factors driving this growth during the forecast period include an increasing demand for biologics, a rising geriatric population, extended healthcare reach in developing markets, an increased occurrence of chronic musculoskeletal disorders, and enhanced investments towards orthopedic drug R&D. Key forecast trends such as improved targeted biologics, the implementation of regenerative medicine treatments, the personalization of drug formulations, advancements in less-invasive delivery methods, increased drug effectiveness through gene therapy, innovative injectable formulations, and the application of artificial intelligence in drug development and clinical decision making are also significant contributors to this growth.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21263&type=smp

What Market Forces Are Contributing To The Growth Of The Prescription Orthopedic Drugs Market?

Growth in the prescription orthopedic drugs market is anticipated to be amplified by the rising prevalence of musculoskeletal conditions. Such conditions, known as Musculoskeletal disorders (MSDs), include ailments and injuries that detrimentally impact the operation of the human body’s musculoskeletal setup consisting of muscles, tendons, ligaments, nerves, and joints. This leads to discomfort and a decline in mobility. The mounting occurrence of these disorders is chiefly attributable to factors like aging, occupational tasks involving recurring movements and awkward body positions, lifestyle decisions such as insufficient physical activity and poor diet, and genetic factors. Critical in addressing these maladies, prescription orthopedic drugs mitigate pain, curtail inflammation, and accelerate the recovery process, leading to enhanced mobility and overall life quality. For example, the Office for Health Improvement and Disparities, a UK-based public health government department, reported in March 2023 that, in 2022, the proportion of individuals over 16 with enduring musculoskeletal conditions like arthritis or persistent back or joint issues had risen to 17.6% from 17.0% in 2021. Plus, data from the World Health Organization, a Switzerland-based international organization, in July 2022 indicated that around 1.71 billion people globally experience musculoskeletal ailments. Thus, this growing prevalence of musculoskeletal disorders is propelling the expansion of the prescription orthopedic drugs market.

How Does The Prescription Orthopedic Drugs Market Differ By Segment?

The prescription orthopedic drugs market covered in this report is segmented –

1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Other Drug Types

2) By Application: Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Other Applications

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Indomethacin

2) By Opioids: Morphine, Oxycodone, Hydrocodone, Fentanyl, Tramadol

3) By Corticosteroids: Prednisone, Methylprednisolone, Dexamethasone, Hydrocortisone, Betamethasone

4) By Disease-Modifying Antirheumatic Drugs (DMARDs): Methotrexate, Hydroxychloroquine, Leflunomide, Sulfasalazine, Azathioprine

5) By Other Drug Types: Bisphosphonates, Calcitonin, Monoclonal Antibodies, Muscle Relaxants, Hyaluronic Acid Injections

What New Opportunities Are Emerging From Trends In The Prescription Orthopedic Drugs Market?

Key corporations in the market for prescription orthopedic drugs are concentrating on extending their drugs’ indications to widen their market penetration, improve patient outcomes, and cater to the underserved medical necessities in various orthopedic conditions. In January 2023, for example, Heron Therapeutics Inc., an American biotech firm, was granted FDA approval for extended use of ZYNRELEF (bupivacaine and meloxicam) in both soft tissue and orthopedic procedure, including surgeries of the foot and ankle. This distinctively engineered extended-release solution offers long lasting pain relief for up to 72 hours, potentially removing the requirement for post-surgery opioids. With additional orthopedic and soft tissue procedures now catered to by the widened indication, its applicability in clinical scenarios has been amplified. This trailblazing combination drug offers both local anesthetic and anti-inflammatory upside, positioning it as a comprehensive solution for management of post-surgery pain, thus bettering patient outcomes.

Who Are The Most Influential Companies In The Prescription Orthopedic Drugs Market?

Major companies operating in the prescription orthopedic drugs market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck KGaA, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GSK Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Biogen Inc., UCB S.A., Allergan plc, Penardo Biotech Pvt. Ltd., Horizon Therapeutics plc

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/prescription-orthopedic-drugs-global-market-report

Which Region Is Leading Innovation In The Prescription Orthopedic Drugs Market?

North America was the largest region in the prescription orthopedic drugs market in 2024. The regions covered in the prescription orthopedic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21263&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#What CAGR Is Anticipated for the Inactivated Vaccines Market Through 2029?#_x000D_

In the recent past, there has been a significant expansion in the industry of prescription orthopedic drugs. The market, which was valued at $48.41 billion in 2024, is estimated to reach $51.06 billion in 2025, representing a compound annual growth rate (CAGR) of 5.5%. Various factors have contributed to this growth over the historic period, including a wider awareness of treatments for osteoporosis, a rise in the number of musculoskeletal disorders, an increase in sports-related injuries globally, the growth of the aged population, and the improved accessibility of healthcare services in developing regions._x000D_

_x000D_

The market for prescription orthopedic drugs is projected to experience robust growth in the coming years. The market is set to expand to “$63.86 billion in 2029 with a compound annual growth rate (CAGR) of 5.8%. The surge in the prediction period can be linked to the rising demand for biologics, an uptick in the elderly population, the expansion of healthcare services in emerging marketplaces, an increase in longstanding musculoskeletal disorders, and escalating investments dedicated to research and development of orthopedic drugs. Key trends to look out for during the forecast period encompass advancements in targeted biologics, the rise in the use of regenerative medicine therapies, development of personalized drug mixtures, strides in minimally invasive delivery techniques, boosted drug efficacy via gene therapy, breakthroughs in injectable formulas, and artificial intelligence advancements in drug development and clinical decision-making processes._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=21263&type=smp_x000D_

_x000D_

#What Market Forces Are Driving The Inactivated Vaccines Sector In 2025 And Beyond?#_x000D_

The escalating occurrence of contagious diseases is forecasted to drive an expansion in the inactivated vaccine market. Contagious diseases, which are viruses, bacteria, parasites, or fungi-based illnesses that can be transmitted between individuals, produce a variety of symptoms and health issues. Tuberculosis is a prime example of such diseases. Inactivated vaccines, which use non-living pathogens to trigger an immune response, are highly effective in preventing diseases such as polio, hepatitis A, and influenza. In November 2023, the Centers for Disease Control and Prevention, a key national public health organization in the USA, published an article stating that the count of tuberculosis patients in the USA soared from 8,320 in 2022 to 9,615 in 2023, marking an increase of 1,295 cases. As such, the escalating occurrence of contagious diseases is fueling expansion in the inactivated vaccine market._x000D_

_x000D_

_x000D_

The prescription orthopedic drugs market covered in this report is segmented – _x000D_

_x000D_

1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Other Drug Types_x000D_

2) By Application: Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Other Applications_x000D_

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies_x000D_

_x000D_

Subsegments:_x000D_

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Indomethacin _x000D_

2) By Opioids: Morphine, Oxycodone, Hydrocodone, Fentanyl, Tramadol _x000D_

3) By Corticosteroids: Prednisone, Methylprednisolone, Dexamethasone, Hydrocortisone, Betamethasone _x000D_

4) By Disease-Modifying Antirheumatic Drugs (DMARDs): Methotrexate, Hydroxychloroquine, Leflunomide, Sulfasalazine, Azathioprine _x000D_

5) By Other Drug Types: Bisphosphonates, Calcitonin, Monoclonal Antibodies, Muscle Relaxants, Hyaluronic Acid Injections_x000D_

_x000D_

#What Long-Term Trends Are Likely To Affect The Inactivated Vaccines Market?#_x000D_

Leading firms in the prescription orthopedic drugs market are strategically increasing the indications for their medications to expand their market penetration, improve patient results, and cater to underserved medical needs across various orthopedic conditions. For example, in January 2023, Heron Therapeutics Inc., a biotechnology firm based in the US, secured FDA approval for the extended use of ZYNRELEF (bupivacaine and meloxicam) for soft tissue and orthopedic procedures, encompassing foot and ankle surgeries. This prolonged-release treatment is designed uniquely to provide extended pain alleviation for up to 72 hours, thereby reducing or completely eliminating the necessity for opioids post-surgery. The widened indication currently includes more orthopedic and soft tissue procedures, including foot and ankle surgeries, thereby extending its clinical applicability. Its novel combination of two drugs yields both local anesthetic and anti-inflammatory benefits, positioning it as a holistic solution for managing post-surgery pain and promoting improved patient results._x000D_

_x000D_

#Which Firms Are Considered Leaders In The Inactivated Vaccines Market Space?#_x000D_

Major companies operating in the prescription orthopedic drugs market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck KGaA, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GSK Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Biogen Inc., UCB S.A., Allergan plc, Penardo Biotech Pvt. Ltd., Horizon Therapeutics plc _x000D_

_x000D_

_x000D_

https://www.thebusinessresearchcompany.com/report/prescription-orthopedic-drugs-global-market-report_x000D_

_x000D_

#What Role Do Regional Policies And Investments Play In Inactivated Vaccines Market Expansion?#_x000D_

North America was the largest region in the prescription orthopedic drugs market in 2024. The regions covered in the prescription orthopedic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=21263&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Is the Estimated Market Size of the Prescription Orthopedic Drugs Market In 2029?#_x000D_

The market for prescription orthopedic medications has seen robust expansion in the past few years. The market is projected to rise from $48.41 billion in 2024 to $51.06 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.5%. Factors contributing to this progress during the historic period include an upsurge in musculoskeletal disorders, an aging population, heightened awareness about treatments for osteoporosis, extended healthcare coverage in emerging regions, and a global rise in sports-related injuries._x000D_

_x000D_

The market for prescription orthopedic drugs is anticipated to register significant growth in the approaching years. It is forecasted to hit a value of $63.86 billion in 2029, expanding at a compound annual growth rate (CAGR) of 5.8%. The propelling factors for this growth during the forecast period might be the escalating demand for biologics, growing elderly population, wider healthcare accessibility in budding markets, an increased occurrence of long-term musculoskeletal disorders, and augmented investment in orthopedic drug R&D. The pivotal trends speculated for the forecast period encompass evolvements in targeted biologics, acceptance of regenerative medicine therapies, customization of drug formulations, strides in minimally intrusive delivery techniques, heightened efficacy of drugs through gene therapy, advancements in injectable formulas, and the use of artificial intelligence in drug creation and clinical judgement-making processes._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=21263&type=smp_x000D_

_x000D_

#How Are Key Drivers in the Industry Acting as Catalysts for the Growth of thePrescription Orthopedic Drugs Market?#_x000D_

The growing prevalence of musculoskeletal disorders is likely to stimulate the prescription orthopedic drugs market’s expansion. These disorders, termed as MSDs, emerge as injuries or conditions hindering the functioning and movement of the body’s elements such as muscles, nerves, ligaments, tendons, and joints, causing a decrease in mobility and pain. This surge in musculoskeletal disorders can be mainly attributed to factors including aging, repetitive motions and improper postures during work, poor nutritional habits, lack of physical activity, and genetic tendencies. Prescription orthopedic drugs play a crucial role in the management of these disorders by alleviating pain, reducing inflammation, speeding up the healing process and eventually enhancing mobility and the overall life quality. For example, the Office for Health Improvement and Disparities, a department for public health based in UK, outlined in March 2023 that the percentage of people aged 16 and over dealing with long-term musculoskeletal conditions like arthritis or persistent back or joint issues increased to 17.6% in 2022 from 17.0% in 2021. Moreover, the World Health Organization, an intergovernmental organization headquartered in Switzerland, revealed in July 2022 that about 1.71 billion people globally are grappling with musculoskeletal disorders. Thus, it is evident that the escalating prevalence of musculoskeletal disorders is propelling the growth of the prescription orthopedic drugs market._x000D_

_x000D_

#Which Segments in the Prescription Orthopedic Drugs Offer the Most Growth?#_x000D_

The prescription orthopedic drugs market covered in this report is segmented – _x000D_

_x000D_

1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Other Drug Types_x000D_

2) By Application: Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Other Applications_x000D_

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies_x000D_

_x000D_

Subsegments:_x000D_

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Indomethacin _x000D_

2) By Opioids: Morphine, Oxycodone, Hydrocodone, Fentanyl, Tramadol _x000D_

3) By Corticosteroids: Prednisone, Methylprednisolone, Dexamethasone, Hydrocortisone, Betamethasone _x000D_

4) By Disease-Modifying Antirheumatic Drugs (DMARDs): Methotrexate, Hydroxychloroquine, Leflunomide, Sulfasalazine, Azathioprine _x000D_

5) By Other Drug Types: Bisphosphonates, Calcitonin, Monoclonal Antibodies, Muscle Relaxants, Hyaluronic Acid Injections_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=21263&type=smp_x000D_

_x000D_

#What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of thePrescription Orthopedic Drugs Market?# Market?#_x000D_

North America was the largest region in the prescription orthopedic drugs market in 2024. The regions covered in the prescription orthopedic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Are the Current Market Growth and Trends in the Prescription Orthopedic Drugs Industry?#_x000D_

Leading corporations in the prescription orthopedic drugs market are prioritizing the expansion of their drug indications to widen their market influence, improve patient results, and cater to unfulfilled healthcare requirements in diverse orthopedic conditions. For example, Heron Therapeutics Inc., an American biotech firm, obtained FDA authorization for the broader use of ZYNRELEF (comprising bupivacaine and meloxicam) in soft tissue and orthopedic procedures, like foot and ankle surgeries, in January 2023. This long-lasting solution is specifically created to offer sustained pain relief for up to 72 hours, decreasing or completely removing the necessity for opioids post-surgery. The wider indication now encompasses further orthopedic and soft tissues surgeries, including foot and ankle surgeries, enlarging its clinical pertinence. Its novel dual-drug blend provides both anesthetic and anti-inflammatory benefits, making it an all-round choice for handling post-operative pain with improved patient results._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/prescription-orthopedic-drugs-global-market-report_x000D_

_x000D_

#What Are the Key Elements That Define the Prescription Orthopedic Drugs Market?#_x000D_

Prescription orthopedic drugs refer to medications specifically prescribed to manage conditions affecting the musculoskeletal system, such as bones, joints, muscles, and ligaments. They are used for pain relief, inflammation reduction, and promoting healing in orthopedic injuries or disorders like arthritis, fractures, and tendonitis._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21263_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of thePrescription Orthopedic Drugs Market?

The increasing incidence of musculoskeletal disorders (MSDs) is expected to drive the growth of the prescription orthopedic drugs market. MSDs, which include conditions like arthritis, back pain, and joint problems, are becoming more prevalent, especially among aging populations and those with sedentary lifestyles. The global rise in musculoskeletal disorders is attributed to factors such as physical inactivity, poor nutrition, occupational activities involving repetitive movements, and genetic predispositions. Prescription orthopedic drugs are vital in managing these disorders by alleviating pain, reducing inflammation, and enhancing the healing process. In 2022, about 17.6% of people aged 16 and over in the UK reported having a long-term musculoskeletal condition, highlighting the increasing need for effective orthopedic treatments. The rising prevalence of MSDs globally is driving the growth of the prescription orthopedic drugs market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21263&type=smp

How Will the Growth Rate of thePrescription Orthopedic Drugs Market Impact Industry Trends by 2034?

The prescription orthopedic drugs market has expanded, growing from $48.41 billion in 2024 to $51.55 billion in 2025 at a CAGR of 6.5%. Contributing factors include a higher prevalence of musculoskeletal disorders, an aging population, increased awareness of osteoporosis treatments, improved healthcare access in developing regions, and rising sports-related injuries worldwide.

The prescription orthopedic drugs market is expected to see robust growth, reaching $65.32 billion by 2029 at a CAGR of 6.1%. The main factors driving this growth include the rising demand for biologics, an aging population, improved healthcare access in emerging markets, an increasing prevalence of chronic musculoskeletal conditions, and more investments in orthopedic drug research and development. Key trends include advancements in targeted biologics, the adoption of regenerative medicine therapies, personalized drug formulations, innovations in minimally invasive delivery methods, enhanced efficacy through gene therapy, improved injectable formulations, and the use of AI for drug development and clinical decision-making.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21263

What Are the Current Market Growth and Trends in thePrescription Orthopedic Drugs Market That Industry Players Should Watch?

In the prescription orthopedic drugs market, companies are working on expanding the indications of existing drugs to cover a broader range of orthopedic conditions and improve patient outcomes. For instance, in January 2023, Heron Therapeutics Inc., a US-based biotechnology company, received FDA approval for the expanded use of ZYNRELEF (bupivacaine and meloxicam), an extended-release combination drug. Initially approved for use in specific surgeries, the drug’s indication was broadened to include soft tissue and orthopedic procedures, such as foot and ankle surgeries. ZYNRELEF provides pain relief for up to 72 hours, helping to reduce or eliminate the need for opioid medications after surgery, thus offering a more effective, long-lasting alternative for pain management in orthopedic procedures.

What Are the Major Market Players Making an Impact on thePrescription Orthopedic Drugs Market Growth?

Major companies operating in the prescription orthopedic drugs market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck KGaA, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GSK Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Biogen Inc., UCB S.A., Allergan plc, Penardo Biotech Pvt. Ltd., Horizon Therapeutics plc

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/prescription-orthopedic-drugs-global-market-report

How Are the Key Segments of the Prescription Orthopedic Drugs Market Driving Opportunities and Innovations?

The prescription orthopedic drugs market covered in this report is segmented –

1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Other Drug Types

2) By Application: Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Other Applications

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Indomethacin

2) By Opioids: Morphine, Oxycodone, Hydrocodone, Fentanyl, Tramadol

3) By Corticosteroids: Prednisone, Methylprednisolone, Dexamethasone, Hydrocortisone, Betamethasone

4) By Disease-Modifying Antirheumatic Drugs (DMARDs): Methotrexate, Hydroxychloroquine, Leflunomide, Sulfasalazine, Azathioprine

5) By Other Drug Types: Bisphosphonates, Calcitonin, Monoclonal Antibodies, Muscle Relaxants, Hyaluronic Acid Injections

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=21263&type=smp

What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of thePrescription Orthopedic Drugs Market?# Market Expansion?

North America was the largest region in the prescription orthopedic drugs market in 2024. The regions covered in the prescription orthopedic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Prescription Orthopedic Drugs Market 2025, By The Business Research Company:

Cholesterol Test Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report

Body Fat Reduction Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/body-fat-reduction-global-market-report

Blood Bank Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-bank-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the prescription orthopedic drugs market size evolved in recent years?

The orthopedic medication market has seen significant expansion in recent years, escalating from $48.41 billion in 2024 to an estimated $51.55 billion in 2025. This growth, representing a compound annual growth rate (CAGR) of 6.5%, is attributable to several key factors. These include a heightened incidence of musculoskeletal disorders, a surge in the elderly population, increased awareness of osteoporosis treatments, broader access to healthcare in less developed areas, and a rise in sports-related injuries globally.

What are the predictions for the prescription orthopedic drugs market size in the coming years?

The market size for prescription orthopedic medication is projected to witness significant expansion in the coming years, rising to $65.32 billion in 2029 with a 6.1% compound annual growth rate (CAGR). Various factors could contribute to this growth including an elevating demand for biological medications, an increasing aging population, broader healthcare accessibility in emerging markets, escalating instances of chronic musculoskeletal disorders, and an upsurge in funding for orthopedic drug research and development. The forthcoming years are also expected to see pervasive trends such as progress in targeted biological medicines, the implementation of regenerative medicine therapies, customization in drug formulations, breakthroughs in minimally invasive delivery techniques, a boost in drug efficiency using gene therapy, advancements in injectable formulations, and the introduction of artificial intelligence to aid drug development and clinical decision-making processes.

Get your prescription orthopedic drugs market report here!

https://www.thebusinessresearchcompany.com/report/prescription-orthopedic-drugs-global-market-report

What key factors are fueling the growth of the prescription orthopedic drugs market?

The rise in musculoskeletal disorders is anticipated to push the expansion of the prescription orthopedic drugs market. Musculoskeletal disorders, (MSDs) conditions and injuries that hinder the function and movement of the body’s musculoskeletal system comprising muscles, tendons, ligaments, nerves, and joints, lead to pain and limited mobility. The surge in these disorders is largely due to factors like aging, repetitive and awkward postures in occupational activities, lifestyle habits such as poor nutrition and physical inactivity, and genetic predispositions. Prescription orthopedic drugs are key in handling these disorders as they alleviate pain, decrease inflammation, and aid the healing process, thus boosting mobility and overall life quality. As an example, the Office for Health Improvement and Disparities, a government department for public health in the UK, stated in March 2023 that in 2022, there was a rise in long-term musculoskeletal conditions, such as ongoing back or joint issues or arthritis, in individuals aged 16 and over from 17.0% in 2021 to 17.6%. Furthermore, the World Health Organization, a Switzerland-based intergovernmental organization, reported in July 2022 that around 1.71 billion people globally were suffering from musculoskeletal disorders. Consequently, the rising prevalence of musculoskeletal disorders is propelling the growth of the prescription orthopedic drugs market.

How is the global prescription orthopedic drugs market divided into key segments?

The prescription orthopedic drugs market covered in this report is segmented –

1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Other Drug Types

2) By Application: Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Other Applications

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Indomethacin

2) By Opioids: Morphine, Oxycodone, Hydrocodone, Fentanyl, Tramadol

3) By Corticosteroids: Prednisone, Methylprednisolone, Dexamethasone, Hydrocortisone, Betamethasone

4) By Disease-Modifying Antirheumatic Drugs (DMARDs): Methotrexate, Hydroxychloroquine, Leflunomide, Sulfasalazine, Azathioprine

5) By Other Drug Types: Bisphosphonates, Calcitonin, Monoclonal Antibodies, Muscle Relaxants, Hyaluronic Acid Injections

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21263&type=smp

Who are the key firms paving the way for growth in the prescription orthopedic drugs market?

Major companies operating in the prescription orthopedic drugs market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck KGaA, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GSK Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Biogen Inc., UCB S.A., Allergan plc, Penardo Biotech Pvt. Ltd., Horizon Therapeutics plc

What are the key trends shaping the future of the prescription orthopedic drugs market?

Leading companies in the market for prescription orthopedic drugs are working towards extending the approved indications for their drugs. The intent is to widen their market penetration, improve patient results, and cater to the unaddressed medical needs in the realm of various orthopedic disorders. For example, Heron Therapeutics Inc., an American biotech firm, gained FDA endorsement in January 2023 for the broader use of ZYNRELEF (bupivacaine and meloxicam). This includes its application in soft tissue, and orthopedic procedures such as foot and ankle surgeries. This innovative extended-release formula is inherently crafted to offer extended pain relief, lasting up to 72 hours. This potentially reduces, if not eradicates, the post-surgical dependence on opioids. The newly expanded authorization now includes more orthopedic and soft tissue procedures, making it even more relevant in clinical applications. The pioneering combination of local anesthetic and anti-inflammatory properties positions it as a comprehensive solution for managing post-operative pain, improving patient outcomes in the process.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21263

What regions are contributing significantly to the growth of the prescription orthopedic drugs market?

North America was the largest region in the prescription orthopedic drugs market in 2024. The regions covered in the prescription orthopedic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cholesterol Test Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report

Body Fat Reduction Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/body-fat-reduction-global-market-report

Blood Bank Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-bank-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: